Sunrise Proteins Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.48 M
- Company Age 39 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -45.61%
- Profit Growth -6134.10%
- Ebitda -6134.10%
- Net Worth -0.56%
- Total Assets -0.56%
About Sunrise Proteins
Sunrise Proteins Limited (SPL) is a Public Limited Indian Non-Government Company incorporated in India on 21 June 1985 and has a history of 39 years and seven months. Its registered office is in Kolkata, West Bengal, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.48 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Pareek, Sumit Mazumder, and Manju Mazumder serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899WB1985PLC150540
-
Company No.
150540
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
21 Jun 1985
-
Date of AGM
19 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Who are the key members and board of directors at Sunrise Proteins?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Pareek
|
Director | 10-Aug-2004 | Current |
|
Sumit Mazumder
|
Additional Director | 19-Feb-2024 | Current |
|
Manju Mazumder
|
Additional Director | 19-Feb-2024 | Current |
Financial Performance of Sunrise Proteins.
Sunrise Proteins Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 45.61% decrease. The company also saw a substantial fall in profitability, with a 6134.1% decrease in profit. The company's net worth dipped by a decrease of 0.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunrise Proteins?
In 2017, Sunrise Proteins had a promoter holding of 99.95% and a public holding of 0.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Til LimitedSumit Mazumder is a mutual person
-
Mahan Eximp LimitedRakesh Pareek is a mutual person
-
Supriya Leasing Limited
Rakesh Pareek, Sumit Mazumder and 1 more are mutual person
-
Arihant Merchants Limited
Rakesh Pareek is a mutual person
-
Bp Commodities Pvt Ltd
Sumit Mazumder and Manju Mazumder are mutual person
-
Gokul Leasing And Finance Private Limited
Sumit Mazumder and Manju Mazumder are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sunrise Proteins?
Unlock and access historical data on people associated with Sunrise Proteins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunrise Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunrise Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.